The Association among Blood Pressure, Blood Pressure Medications, and Glaucoma in a Nationwide Electronic Health Records Database
- PMID: 34688700
- PMCID: PMC8863625
- DOI: 10.1016/j.ophtha.2021.10.018
The Association among Blood Pressure, Blood Pressure Medications, and Glaucoma in a Nationwide Electronic Health Records Database
Abstract
Purpose: To measure the association among blood pressure (BP), BP medications, and glaucoma using the All of Us Research Program database.
Design: A retrospective, longitudinal cohort study leveraging a national electronic health record (EHR) database administered by the National Institutes of Health.
Participants: Eye patients in the All of Us Research Program database with at least 15 months of follow-up and 1 BP measurement.
Methods: Univariable and multivariable Cox regression models predicted the risk of developing incident open-angle glaucoma (OAG). Mean arterial pressure (MAP) and the number of BP medication classes were entered as time-varying predictors to account for changes over time.
Main outcome measures: The risk of developing incident OAG, as defined by billing diagnosis codes.
Results: Of 20 815 eligible eye patients who qualified for this study, 462 developed OAG. Low BP (MAP < 83.0 mmHg) was associated with increased risk of developing OAG (hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.04-1.67). High BP (MAP > 101.3 mmHg) and the number of BP medication classes were not associated with OAG after adjustment for covariates. Other risk factors associated with OAG included being Black (HR, 3.31, 95% CI, 2.63-4.17), Hispanic or Latino (HR, 2.53, 95% CI, 1.94-3.28), Asian (HR, 2.22, 95% CI, 1.24-3.97), older in age (80+ years, HR, 20.1, 95% CI, 9.10-44.5), and diabetic (HR, 1.32, 95% CI, 1.04-1.67). Female gender was associated with decreased hazard of developing OAG (HR, 0.66, 95% CI, 0.55-0.80). No significant interaction was observed between MAP and the number of BP medications on the risk of developing OAG.
Conclusions: We found that low BP is associated with increased risk of developing OAG in a national longitudinal EHR database. We did not find evidence supporting a differential effect of medically treated and untreated low BP. This study adds to the body of literature implicating vascular dysregulation as a potential etiology for the development of OAG, particularly emphasizing the lack of influence of BP medications on this relationship.
Keywords: Blood pressure; Blood pressure medications; Electronic health records; Glaucoma; Risk factors.
Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. - PubMed
-
- Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183–2193. - PubMed
-
- Leske MC, Wu S-Y, Hennis A, Honkanen R, Nemesure B, BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85–93. - PubMed
-
- Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006;47(10):4254–4261. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- OT2 OD026556/OD/NIH HHS/United States
- P30 EY026877/EY/NEI NIH HHS/United States
- U2C OD023196/OD/NIH HHS/United States
- OT2 OD025315/OD/NIH HHS/United States
- OT2 OD026551/OD/NIH HHS/United States
- U24 OD023121/OD/NIH HHS/United States
- OT2 OD026552/OD/NIH HHS/United States
- OT2 OD026549/OD/NIH HHS/United States
- OT2 OD025337/OD/NIH HHS/United States
- OT2 OD025277/OD/NIH HHS/United States
- OT2 OD026555/OD/NIH HHS/United States
- OT2 OD026550/OD/NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
- OT2 OD023205/OD/NIH HHS/United States
- OT2 OD025276/OD/NIH HHS/United States
- OT2 OD026557/OD/NIH HHS/United States
- OT2 OD026554/OD/NIH HHS/United States
- U24 OD023163/OD/NIH HHS/United States
- OT2 OD023206/OD/NIH HHS/United States
- U24 OD023176/OD/NIH HHS/United States
- OT2 OD026548/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical